TNFRSF9 and colon carcinoma: On the other hand, in a recent study, delivery of three consecutive weekly doses of 150 μg of a different anti-4-1BB agonistic antibody (clone 1D8 or 2A) to mice resulted in significant T cell mediated liver inflammation and immunopathology, without control of a murine colon carcinoma [55].